Inactivation of traP has no effect on the Agr quorum-sensing system or virulence of Staphylococcus aureus

Infection and Immunity

Volumn 75, Issue 9, 2007, Pages 4519-4527

  Shaw, Lindsey N ^a   Jonsson, Ing Marie ^b   Singh, Vineet K ^c   Tarkowski, Andrej ^b   Stewart, George C ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c A T STILL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; MUTANT PROTEIN; PROTEIN AGR; PROTEIN TRAP; UNCLASSIFIED DRUG;

AGR GENE; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INACTIVATION; HEMOLYSIS; HLA GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING; REGULATOR GENE; SPA GENE; SSPA GENE; STAPHYLOCOCCUS AUREUS; TRAP GENE;

ANIMALS; ARTHRITIS, INFECTIOUS; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENE SILENCING; HEMOLYSIS; MICE; QUORUM SENSING; RNA-BINDING PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; VIRULENCE;

EID: 34548491442     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00491-07     Document Type: Article

References (74)

1. Abdelnour, A., S. Arvidson, T. Bremell, C. Ryden, and A. Tarkowski. 1993. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect. Immun. 61:3879-3885.
2. Anguita-Alonso, P., A Giacometti, O. Cirioni, R. Ghiselli, F. Orlando, V. Saba, G. Scalise, M. Sevo, R. Patel, and N. Balaban. 2007. RNAIII-inhibiting peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation. Antimicrob. Agents Chemother. 51:2594-2596.
3. Arvidson, S., and K. Tegmark. 2001. Regulation of virulence determinants in Staphylococcus aureus. Int. J. Med. Microbiol. 291:159-170.
4. Balaban, N., O. Cirioni, A. Giacometti, R. Ghiselli, J. B. Braunstein, C. Silvestri, F. Mocchegiani, V. Saba, and G. Scalise. 2007. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob. Agents Chemother. 51:2226-2229.
5. Balaban, N., L. V. Collins, J. S. Cullor, E. B. Hume, E. Medina-Acosta, O. Vieira da Motta, R. O'Callaghan, P. V. Rossitto, M. E. Shirtliff, L. Serafim da Silveira, A. Tarkowski, and J. V. Torres. 2000. Prevention of diseases caused by Staphylococcus aureus using the peptide RIP. Peptides 21:1301-1311.
6. Balaban, N., A. Giacometti, O. Cirioni, Y. Gov, R. Ghiselli, F. Mocchegiani, C. Viticchi, M. S. Del Prete, V. Saba, G. Scalise, and G. Dell'Acqua. 2003. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J. Infect. Dis. 187:625-630.
7. Balaban, N., T. Goldkorn, Y. Gov, M. Hirshberg, N. Koyfman, H. R. Matthews, R. T. Nhan, B. Singh, and O. Uziel. 2001. Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating protein (TRAP). J. Biol. Chem. 276:2658-2667.
8. Balaban, N., T. Goldkorn, R. T. Nhan, L. B. Dang, S. Scott, R. M. Ridgley, A. Rasooly, S. C. Wright, J. W. Larrick, R. Rasooly, and J. R. Carlson. 1998. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 280:438-440.
9. Balaban, N., and R. P. Novick. 1995. Autocrine regulation of toxin synthesis by Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 92:1619-1623.
10. Balaban, N., B. Singh, T. Goldkorn, A. Rasooly, J. V. Torres, and O. Uziel. 2000. Activation and inhibition of the staphylococcal AGR system. Science 287:391a.
11. Balaban, N., P. Stoodley, C. A. Fux, S. Wilson, J. W. Costerton, and G. Dell'Acqua. 2005. Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP. Clin. Orthoped. Rel. Res. 437:48-54.
12. B regulon. J. Bacteriol. 186:4085-4099.
13. Bjorklind, A., and S. Arvidson. 1980. Mutants of Staphylococcus aureus affected in the regulation of exoprotein synthesis. FEMS Microbiol. Lett. 7:203-206.
14. Chan, P. F., and S. J. Foster. 1998. The role of environmental factors in the regulation of virulence-determinant expression in Staphylococcus aureus 8325-4. Microbiology144:2469-2479.
15. Chan, P. F., and S. J. Foster. 1998. Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus. J. Bacteriol. 180:6232-6241.
16. Cheung, A. L., J. M. Koomey, C. A. Butler, S. J. Projan, and V. A. Fischetti. 1992. Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc. Natl. Acad. Sci. USA 89:6462-6466.
17. Cheung, A. L., and P. Ying. 1994. Regulation of alpha- and beta-hemolysins by the sar locus of Staphylococcus aureus. J. Bacteriol. 176:580-585.
18. Cheung, A. L., and G. Zhang. 2002. Global regulation of virulence determinants in Staphylococcus aureus by the SarA protein family. Front. Biosci. 7:1825-1842.
19. Cirioni, O., A. Giacometti, R. Ghiselli, G. Dell'Acqua, Y. Gov, W. Kamysz, J. Lukasiak, F. Mocchegiani, F. Orlando, G. D'Amato, N. Balaban, V. Saba, and G. Scalise. 2003. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides. Circulation 108:767-771.
20. Cirioni, O., A. Giacometti, R. Ghiselli, G. Dell'Acqua, F. Orlando, F. Mocchegiani, C. Silvestri, A. Licci, V. Saba, G. Scalise, and N. Balaban. 2006. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. J. Infect. Dis. 193:180-186.
21. Dell'Acqua, G., A. Giacometti, O. Cirioni, R. Ghiselli, V. Saba, G. Scalise, Y. Gov, and N. Balaban. 2004. Suppression of drug-resistant staphylococcal infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. J. Infect. Dis. 190:318-320.
22. B of Staphylococcus aureus: characterization and role in transcription of the global regulatory locus sar. J. Bacteriol. 179:6355-6359.
23. Domenico, P., E. Gurzenda, A. Giacometti, O. Cirioni, R. Ghiselli, F. Orlando, M. Korem, V. Saba, G. Scalise, and N. Balaban. 2004. BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. Peptides 25:2047-2053.
24. Dunman, P. M., E. Murphy, S. Haney, D. Palacios, G. Tucker-Kellogg, S. Wu, E. L. Brown, R. J. Zagursky, D. Shlaes, and S. J. Projan. 2001. Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J. Bacteriol. 183:7341-7353.
25. Duthie, E. S., and L. L. Lorenz. 1952. Staphylococcal coagulase; mode of action and antigenicity. J. Gen. Microbiol. 6:95-107.
26. Fournier, B., A. Klier, and G. Rapoport. 2001. The two-component system ArlS-ArlR is a regulator of virulence gene expression in Staphylococcus aureus. Mol. Microbiol. 41:247-261.
27. Ghiselli, R., A. Giacometti, O. Cirioni, G. Dell'Acqua, C. Bergnach, F. Orlando, F. Mocchegiani, C. Silvestri, B. Skerlavaj, A. Licci, N. Balaban, M. Zanetti, G. Scalise, and V. Saba. 2006. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis. Shock 26:296-301.
28. Giacometti, A., O. Cirioni, R. Ghiselli, G. Dell'Acqua, F. Orlando, G. D'Amato, F. Mocchegiani, C. Silvestri, M. S. Del Prete, M. Rocchi, N. Balaban, V. Saba, and G. Scalise. 2005. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. Peptides 26:169-175.
29. Giacometti, A., O. Cirioni, Y. Gov, R. Ghiselli, M. S. Del Prete, F. Mocchegiani, V. Saba, F. Orlando, G. Scalise, N. Balaban, and G. Dell'Acqua. 2003. RNA III-inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:1979-1983.
30. Giraudo, A. T., C. G. Raspanti, A. Calzolari, and R. Nagel. 1994. Characterization of a Tn551-mutant of Staphylococcus aureus defective in the production of several exoproteins. Can. J. Microbiol. 40:677-681.
31. Gov, Y., I. Borovok, M. Korem, V. K. Singh, R. K. Jayaswal, B. J. Wilkinson, S. M. Rich, and N. Balaban. 2004. Quorum sensing in staphylococci is regulated via phosphorylation of three conserved histidine residues. J. Biol. Chem. 279:14665-14672.
32. B modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J. Bacteriol. 184:5457-5467.
33. Janzon, L., and S. Arvidson. 1990. The role of the delta-lysin gene (hld) in the regulation of virulence genes by the accessory gene regulator (agr) in Staphylococcus aureus. EMBO J. 9:1391-1399.
34. Janzon, L., S. Lofdahl, and S. Arvidson. 1989. Identification and nucleotide sequence of the delta-lysin gene, hld, adjacent to the accessory gene regulator (agr) of Staphylococcus aureus. Mol. Gen. Genet. 219:480-485.
35. Ji, G., R. Beavis, and R. P. Novick. 1997. Bacterial interference caused by autoinducing peptide variants. Science 276:2027-2030.
36. Ji, G., R. C. Beavis, and R. P. Novick. 1995. Cell density control of staphylococcal virulence mediated by an octapeptide pheromone. Proc. Natl. Acad. Sci. USA 92:12055-12059.
37. Korem, M., Y. Gov, M. D. Kiran, and N. Balaban. 2005. Transcriptional profiling of target of RNAIII-activating protein, a master regulator of staphylococcal virulence. Infect. Immun. 73:6220-6228.
38. Korem, M., A. S. Sheoran, Y. Gov, S. Tzipori, I. Borovok, and N. Balaban. 2003. Characterization of RAP, a quorum sensing activator of Staphylococcus aureus. FEMS Microbiol. Lett. 223:167-175.
39. Kornblum, J., B. N. Kreiswirth, S. J. Projan, H. F. Ross, and R. P. Novick. 1990. Agr: a polycistronic locus regulating exoprotein synthesis in Staphylococcus aureus, p. 373-402. In R. P. Novick (ed.), Molecular biology of the staphylococci. VCH Publishers, New York, NY.
40. Lina, G., S. Jarraud, G. Ji, T. Greenland, A. Pedraza, J. Etienne, R. P. Novick, and F. Vandenesch. 1998. Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus. Molec. Microbiol. 28:655-662.
41. Lindsay, J. A., and S. J. Foster. 1999. Interactive regulatory pathways control virulence determinant production and stability in response to environmental conditions in Staphylococcus aureus. Mol. Gen. Genet. 262:323-331.
42. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520-532.
43. Mayville, P., G. Ji, R. Beavis, H. Yang, M. Goger, R. P. Novick, and T. W. Muir. 1999. Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence. Proc. Natl. Acad. Sci. USA 96:1218-1223.
44. McAleese, F. M., E. J. Walsh, M. Sieprawska, J. Potempa, and T. J. Foster. 2001. Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease. J. Biol. Chem. 276:29969-29978.
45. McNamara, P. J., and J. J. Iandolo. 1998. Genetic instability of the global regulator agr explains the phenotype of the xpr mutation in Staphylococcus aureus KSI9051. J. Bacteriol. 180:2609-2615.
46. Morfeldt, E., I. Panova-Sapundjieva, B. Gustafsson, and S. Arvidson. 1996. Detection of the response regulator AgrA in the cytosolic fraction of Staphylococcus aureus by monoclonal antibodies. FEMS Microbiol. Lett. 143:195-201.
47. Novick, R. P. 2003. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48:1429-1449.
48. Novick, R. P. 2000. Pathogenicity factors and their regulation, p. 392-407. In V. A. Fischetti, R. P. Novick, J. J. Ferretti, D. A. Portnoy, and J. I. Rood (ed.), Gram-positive pathogens. ASM Press, Washington, DC.
49. Novick, R. P., S. J. Projan, J. Kornblum, H. F. Ross, G. Ji, B. Kreiswirth, F. Vandenesch, and S. Moghazeh. 1995. The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol. Gen. Genet. 248:446-458.
50. Novick, R. P., H. F. Ross, A. M. S. Figueiredo, G. Abramochkin, and T. Wuir. 2000. Activation and inhibition of the staphylococcal AGR system. Science 287:391a.
51. Novick, R. P., H. F. Ross, S. J. Projan, J. Kornblum, B. Kreiswirth, and S. Moghazeh. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12:3967-3975.
52. Otto, M. 2004. Quorum-sensing control in staphylococci - a target for antimicrobial drug therapy? FEMS Microbiol. Lett. 241:135-141.
53. Otto, M., R. Sussmuth, G. Jung, and F. Gotz. 1998. Structure of the pheromone peptide of the Staphylococcus epidermidis agr system. FEBS Lett. 424:89-94.
54. Patel, A. H., J. Kornblum, B. Kreiswirth, R. Novick, and T. J. Foster. 1992. Regulation of the protein A-encoding gene in Staphylococcus aureus. Gene 114:25-34.
55. Peng, H. L., R. P. Novick, B. Kreiswirth, J. Kornblum, and P. Schlievert. 1988. Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. J. Bacteriol. 170:4365-4372.
56. Qiu, R., W. Pei, L. Zhang, J. Lin, and G. Ji. 2005. Identification of the putative staphylococcal AgrB catalytic residues involving the proteolytic cleavage of AgrD to generate autoinducing peptide. J. Biol. Chem. 280:16695-16704.
57. Ribeiro, P. D., O. D. Ribeiro, A. M. Marcolan, and E. Medina-Acosta. 2003. Treatment efficacy of the lead RNAIII-inhibiting peptide YSPWTNF-NH2 in acquired Staphylococcus aureus sepsis: a histopathological assessment. Peptides 24:1829-1836.
58. Shaw, L., E. Golonka, J. Potempa, and S. J. Foster. 2004. The role and regulation of the extracellular proteases of Staphylococcus aureus. Microbiology 150:217-228.
59. B-modulated regulatory pathways governing extracellular virulence determinant production in Staphylococcus aureus. J. Bacteriol. 188:6070-6080.
60. Shaw, L. N., E. Golonka, G. Szmyd, S. J. Foster, J. Travis, and J. Potempa. 2005. Cytoplasmic control of premature activation of a secreted protease zymogen: deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a profound pleiotropic phenotype. J. Bacteriol. 187:1751-1762.
61. Singh, V. K., R. K. Jayaswal, and B. J. Wilkinson. 2001. Cell wall-active antibiotic induced proteins of Staphylococcus aureus identified using a proteomic approach. FEMS Microbiol. Lett. 199:79-84.
62. Somerville, G. A., S. B. Beres, J. R. Fitzgerald, F. R. DeLeo, R. L. Cole, J. S. Hoff, and J. M. Musser. 2002. In vitro serial passage of Staphylococcus aureus: changes in physiology, virulence factor production, and agr nucleotide sequence. J. Bacteriol. 184:1430-1437.
63. Tarkowski, A., M. Bokarewa, L. V. Collins, I. Gjertsson, O. H. Hultgren, T. Jin, I. M. Jonsson, E. Josefsson, E. Sakiniene, and M. Verdrengh. 2002. Current status of pathogenetic mechanisms in staphylococcal arthritis. FEMS Microbiol. Lett. 217:125-132.
64. Traber, K., and R. Novick. 2006. A slipped-mispairing mutation in AgrA of laboratory strains and clinical isolates results in delayed activation of agr and failure to translate δ- and α-hemolysins. Mol. Microbiol. 59:1519-1530.
65. Vandenesch, F., J. Kornblum, and R. P. Novick. 1991. A temporal signal, independent of agr, is required for hla but not spa transcription in Staphylococcus aureus. J. Bacteriol. 173:6313-6320.
66. Vieira-da-Motta, O., P. D. Ribeiro, W. Dias da Silva, and E. Medina-Acosta. 2001. RNAIII inhibiting peptide (RIP) inhibits agr-regulated toxin production. Peptides 22:1621-1627.
67. Vuong, C., S. Kocianova, Y. Yao, A. B. Carmody, and M. Otto. 2004. Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. J. Infect. Dis. 190:1498-1505.
68. Vuong, C., H. L. Saenz, F. Gotz, and M. Otto. 2000. Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J. Infect. Dis. 182:1688-1693.
69. Wright, J. S., III, R. Jin, and R. P. Novick. 2005. Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc. Natl. Acad. Sci. USA 102:1691-1696.
70. Yang, G., H. Cheng, C. Liu, Y. Xue, Y. Gao, N. Liu, B. Gao, D. Wang, S. Li, B. Shen, and N. Shao. 2003. Inhibition of Staphylococcus aureus pathogenesis in vitro and in vivo by RAP-binding peptides. Peptides 24:1823-1828.
71. Yarwood, J. M., J. K. McCormick, and P. M. Schlievert. 2001. Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus. J. Bacteriol. 183:1113-1123.
72. Zhang, L., L. Gray, R. P. Novick, and G. Ji. 2002. Transmembrane topology of AgrB, the protein involved in the post-translational modification of AgrD in Staphylococcus aureus. J. Biol. Chem. 277:34736-34742.
73. Zhang, L., J. Lin, and G. Ji. 2004. Membrane anchoring of the AgrD N-terminal amphipathic region is required for its processing to produce a quorum-sensing pheromone in Staphylococcus aureus. J. Biol. Chem. 279:19448-19456.
74. B in growth phase dependent regulation of virulence factors in Staphylococcus aureus. Proteomics 4:3034-3047.